InflaRx N.V (IFRX) concluded trading on Wednesday at a closing price of $0.73, with 7.94 million shares of worth about $5.8 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -64.54% during that period and on Wednesday the price saw a loss of about -59.86%. Currently the company’s common shares owned by public are about 67.75M shares, out of which, 57.08M shares are available for trading.
Stock saw a price change of -58.73% in past 5 days and over the past one month there was a price change of -40.12%. Year-to-date (YTD), IFRX shares are showing a performance of -70.43% which decreased to -50.64% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.82 but also hit the highest price of $2.82 during that period. The average intraday trading volume for InflaRx N.V shares is 301.24K. The stock is currently trading -56.27% below its 20-day simple moving average (SMA20), while that difference is down -46.11% for SMA50 and it goes to -57.70% lower than SMA200.
InflaRx N.V (NASDAQ: IFRX) currently have 67.75M outstanding shares and institutions hold larger chunk of about 26.11% of that.
The stock has a current market capitalization of $49.04M and its 3Y-monthly beta is at 1.53. It has posted earnings per share of -$1.05 in the same period. It has Quick Ratio of 4.86 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IFRX, volatility over the week remained 47.03% while standing at 21.58% over the month.
Analysts are in expectations that InflaRx N.V (IFRX) stock would likely to be making an EPS of -0.21 in the current quarter, while forecast for next quarter EPS is -0.15 and it is -0.53 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.22 which is -0.19 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.24 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 15.94% while it is estimated to increase by 3.08% in next year. EPS is likely to shrink at an annualized rate of 14.30% for next 5-years, compared to annual growth of 18.08% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Cantor Fitzgerald on April 29, 2025 offering an Overweight rating for the stock and assigned a target price of $10 to it. Coverage by Guggenheim stated InflaRx N.V (IFRX) stock as a Buy in their note to investors on April 05, 2023, suggesting a price target of $8 for the stock. On February 28, 2022, Guggenheim Downgrade their recommendations, while on October 28, 2021, Raymond James Upgrade their ratings for the stock with a price target of $14. Stock get a Buy rating from Guggenheim on March 11, 2021.
